Latest Breaking News On - அனில் ஜெயின் - Page 1 : comparemela.com
Getting To Know The BJP Leader: Anil Jain, A Positive Influence
outlookindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from outlookindia.com Daily Mail and Mail on Sunday newspapers.
Franklin Templeton MF: SC says SAT direction of ₹250-crore deposit is fair
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.
E-Biotorium launches Bio Magnetic Products
Excelsior Correspondent
JAMMU, July 24: E-Biotorium, group of companies dealing in bio-magnetic products showcased their products and their usage for the benefit of human health and environment.
In a press conference here today Sagar Joshi, CMD of E-Biotorium gave full description about the company, its products and its working progress across the world.
In the inaugural address, Jay Dev Rajwal, J&K Head of the company welcomed the CMD of the company along with the other dignitaries and informed the gathering about company’s structure and future in J&K.
He named some of the products the company will deal in Jammu as Water Energy Pads, Mattress and said that these Mattresses are specially designed using magnets to regulate blood circulation and oxygen levels in human body when put to use.
PM Modi, BJP leaders observe day-long fast to target Congress over washout of Budget Session
newsnationtv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsnationtv.com Daily Mail and Mail on Sunday newspapers.
Bajaj Healthcare has received a licence from DRDO to manufacture and market of 2-Deoxy-D-Glucose (2-DG) as approved medication for the treatment of COVID-19 patients.
The Defence Research and Development Organisation (DRDO) has granted permissions to manufacture and market the 2-Deoxy-D-Glucose in the domestic market.
2-DG helps in the faster recovery of hospitalised patients and reduces supplemental oxygen dependence. The drug works by selectively accumulating in the virus-infected cells and prevents virus growth by stopping viral synthesis and energy production. It can be administered only upon prescription and under the supervision of a qualified physician to hospitalised moderate to severe COVI D-19 patients as an adjunct therapy to the existing standard of care.